APA (7th ed.) Citation

GC, M., R, G., S, B., S, G., X, W., ML, P., . . . JA, S. (2025). Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: A cross-sectional analysis of the prospective SAIL-RA cohort in the USA. The Lancet. Rheumatology, 7(12), e851. https://doi.org/10.1016/S2665-9913(25)00158-4

Chicago Style (17th ed.) Citation

GC, McDermott, et al. "Risk Factors for Interstitial Lung Disease in Early Rheumatoid Arthritis and External Validation of Screening Strategies: A Cross-sectional Analysis of the Prospective SAIL-RA Cohort in the USA." The Lancet. Rheumatology 7, no. 12 (2025): e851. https://doi.org/10.1016/S2665-9913(25)00158-4.

MLA (9th ed.) Citation

GC, McDermott, et al. "Risk Factors for Interstitial Lung Disease in Early Rheumatoid Arthritis and External Validation of Screening Strategies: A Cross-sectional Analysis of the Prospective SAIL-RA Cohort in the USA." The Lancet. Rheumatology, vol. 7, no. 12, 2025, p. e851, https://doi.org/10.1016/S2665-9913(25)00158-4.